Skip to main content

Table 1 Sample sizes of 13 tumor types before and after filtering to ensure sufficient mutations per sample and total samples.

From: Network-based stratification analysis of 13 major cancer types using mutations in panels of cancer genes

Cancera,b Sample size Full
(# mutations ≥ 6)
FoundationOne
(# mutations ≥ 1)
PanCan
(# mutations ≥ 1)
TrueSeq
(# mutations ≥1)
BLCA 99 99 (100%) 97(98%) 95 (96%) 84 (85%)
BRCA 887 849 (96%) 661 (75%) 647 (73%) 528 (60%)
CRC 233 233 (100%) 227 (97%) 226 (97%) 219 (94%)
ESO 140 140 (100%) 133 (95%) 125 (89%) 112 (80%)
GBM 291 288 (99%) 247 (85%) 237 (81%) 199 (68%)
HNSC 384 372 (97%) 357 (93%) 347 (90%) 303 (79%)
KIRC 417 414 (99%) 328 (79%) 310 (74%) 220 (53%)
LUAD 398 391 (98%) 372 (93%) 359 (90%) 322 (81%)
LUSC 176 176 (100%) 176 (100%) 175 (99%) 158 (90%)
MEL 118 118 (100%) 117 (99%) 113 (96%) 112 (95%)
MM 204 200 (98%) 157 (77%) 146 (72%) 121(59%)
OV 316 313 (99%) 276 (87%) 281 (89%) 238 (75%)
UCEC 247 247 (100%) 245 (%99) 242 (98%) 229 (93%)
Total 4143 4008    
  1. aBLCA-Bladder urothelial carcinoma; BRCA-Breast invasive carcinoma; CRC-Colorectal carcinoma; ESO-Esophageal adenocarcinoma; GBM-Glioblastoma multiforme; HNSC-Head and neck squamous cell carcinoma; KIRC-Kidney renal clear cell carcinoma; LUAD-Lung adenocarcinoma; LUSC-Lung squamous cell carcinoma; MEL-Melanoma; MM-Multiple myeloma; OV-Ovarian serous cystadenocarcinoma; UCEC-Uterine corpus endometrial carcinoma
  2. bCancer types with survival data: BLCA, BRCA, CRC, ESO, GBM, HNSC, KIRC, LUAD, LUSC, OV,UCEC.